Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-31 @ 1:49 PM
Study NCT ID:
NCT03124459
Status:
TERMINATED
Last Update Posted:
2022-09-26
First Post:
2017-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-12
First Submit QC Date:
None
Study First Post Date:
2017-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-11
Results First Submit QC Date:
None
Results First Post Date:
2021-07-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-13
Last Update Post Date:
2022-09-26
Last Update Post Date Type:
ACTUAL